Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

PURPOSE: To assess the efficacy, safety, and quality-of-life impact of switching adjuvant treatment in hormone receptor-positive primary breast cancer patients who are still premenopausal after 2–3 years of tamoxifen therapy to anastrozole plus goserelin as compared with continuing tamoxifen over a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Main Authors: Li, Jian-wei, Liu, Guang-yu, Ji, Ya-jie, Yan, Xia, Pang, Da, Jiang, Ze-fei, Chen, De-dian, Zhang, Bin, Xu, Bing-he, Shao, Zhi-ming
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312049/
https://ncbi.nlm.nih.gov/pubmed/30643455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183672
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares